STRS Ohio’s Achieve Life Sciences ACHV Stock Holding History

STRS Ohio’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6,400	Closed	-$30.1K	–	1960
2024 Q2	$30.1K	Buy	+6,400	New	+$30.8K	﹤0.01%	1851

Other funds holding ACHV

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

STRS Ohio's ACHV Position: Q3 2024 in Review

STRS Ohio sold out of Achieve Life Sciences (ACHV) in Q3 2024, closing a stake of 6,400 shares — an estimated $30.1K sold.

STRS Ohio first reported a position in ACHV in Q2 2024 and held it in 1 quarter. The position peaked at $30.1K in Q2 2024. 64 funds tracked by Wall St. Rank hold ACHV as of Q3 2024.

STRS Ohio reported no remaining Achieve Life Sciences position as of Q3 2024 after selling out during the quarter.
STRS Ohio sold 6,400 Achieve Life Sciences shares in Q3 2024, an estimated $30.1K.
STRS Ohio first reported a position in Achieve Life Sciences in Q2 2024 and held it in 1 quarter.
STRS Ohio's Achieve Life Sciences position peaked at $30.1K in Q2 2024.
64 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2024.

Based on STRS Ohio's 13F filing for Q3 2024, filed 1 Nov 2024.